Philip Morris Raises Its Dividend 8.8% as Coverage Tightens

Philip Morris International raised its quarterly dividend to $1.60 from $1.47, an 8.8% increase that lifts the annualized payout to $6.40 a share. At a cited share price of $204.54, the new rate implied a yield of about 3.1%.

The increase is supported by earnings growth, but the payout already absorbs most of the company's expected profit. Philip Morris forecasts 2026 adjusted diluted earnings per share of $8.26 to $8.41. Dividing the $6.40 annual dividend by that range produces a payout ratio of roughly 76% to 77%.

Cash flow tells a similar story. In 2025, operating cash flow was $12.23 billion and capital spending was $1.57 billion, leaving about $10.66 billion before financing activities. Dividends consumed $8.62 billion, or about 81% of that amount. The calculation is useful, but it is not company guidance and can move with working capital, taxes and currency.

The growth engine is increasingly outside cigarettes. Second-quarter net revenue rose 10.4% to $11.19 billion, adjusted earnings of $2.20 a share exceeded the cited $2.05 consensus, and smoke-free revenue increased 14.2%. VEEV volume rose 55.1%, while the FDA granted modified-risk status to ZYN products on June 30.

Balance-sheet capacity is the main constraint. Net debt was reported at about $43.1 billion, or 2.35 times adjusted EBITDA, above management's goal of roughly 2 times. The company expects about $13.5 billion of operating cash flow in 2026 and $1.4 billion to $1.6 billion of capital spending, but it is not planning share repurchases. That prioritization leaves room for debt reduction and the dividend, not every form of capital return at once.

The latest increase looks affordable if earnings and smoke-free sales continue to grow. Another raise of similar size would require more. Investors should watch free cash flow after capital spending, net leverage and the pace at which ZYN, IQOS and VEEV replace the economics of cigarettes.